AP-3

N/A

Report date: 2025/12/31 10:07:38

Base Information

Drug NameAP-3
Drug Alias NameAP-3AP3
ClassificationOther
Mechanisms of ActionTau-tubulin kinase 1 inhibitors
TargetsTau-tubulin kinase 1
Therapy Area/IndicationsFrontotemporal DementiaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMolefy Pharma SL
China Registration ClassN/A

Develop Information

Active CompaniesMolefy Pharma SL
Inactive CompaniesN/A
Active IndicationsFrontotemporal DementiaAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A